RLYP - interesting bio

I’m not sure that this company fits the standard metrics most of the board uses, but definitely one to keep an eye on.

If their drug starts selling with the expected opportunities, it will likely be a fast revenue grower that will fit the style.

May be early but I bought a starter. Trying to share some ideas beyond the price action of stocks too.